BACKGROUND: Recent genome-wide association studies have identified several chromosome 9p21 single nucleotide polymorphisms associated with coronary artery disease and myocardial infarction in nonsurgical populations. We have recently demonstrated an independent association between these 9p21 variants and perioperative myocardial injury after isolated primary coronary artery bypass graft (CABG) surgery. This study investigated the association of a 9p21 variant with mortality in patients after CABG surgery and its prognostic value to improve the EuroSCORE. METHODS AND RESULTS: In a 2-center, prospective, observational study of 846 white primary CABG surgery patients, we genotyped rs10116277, the 9p21 variant with the strongest association to perioperative myocardial injury in our cohort. To estimate the utility of rs10116277 for predicting all-cause mortality within 5 years after surgery, a Cox proportional hazard model was constructed to estimate the hazard ratios (HR) and 95% confidence intervals (CI) while adjusting for demographics and clinical covariates. The homozygote minor allele of rs10116277 was associated with significantly increased risk of all-cause mortality even after adjusting for other clinical predictors of mortality in a Cox proportional hazards model (HR, 1.7; 95% CI, 1.1-2.7; P=0.026). Addition of rs10116277 to the logistic EuroSCORE also significantly improved model prediction for mortality (HR, 1.82; 95% CI, 1.15-2.88; P=0.01). CONCLUSIONS: The 9p21 variant rs10116277 is independently associated with all-cause mortality after primary CABG surgery in whites and significantly improves the predictive value of the logistic EuroSCORE. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00281164.
BACKGROUND: Recent genome-wide association studies have identified several chromosome 9p21 single nucleotide polymorphisms associated with coronary artery disease and myocardial infarction in nonsurgical populations. We have recently demonstrated an independent association between these 9p21 variants and perioperative myocardial injury after isolated primary coronary artery bypass graft (CABG) surgery. This study investigated the association of a 9p21 variant with mortality in patients after CABG surgery and its prognostic value to improve the EuroSCORE. METHODS AND RESULTS: In a 2-center, prospective, observational study of 846 white primary CABG surgery patients, we genotyped rs10116277, the 9p21 variant with the strongest association to perioperative myocardial injury in our cohort. To estimate the utility of rs10116277 for predicting all-cause mortality within 5 years after surgery, a Cox proportional hazard model was constructed to estimate the hazard ratios (HR) and 95% confidence intervals (CI) while adjusting for demographics and clinical covariates. The homozygote minor allele of rs10116277 was associated with significantly increased risk of all-cause mortality even after adjusting for other clinical predictors of mortality in a Cox proportional hazards model (HR, 1.7; 95% CI, 1.1-2.7; P=0.026). Addition of rs10116277 to the logistic EuroSCORE also significantly improved model prediction for mortality (HR, 1.82; 95% CI, 1.15-2.88; P=0.01). CONCLUSIONS: The 9p21 variant rs10116277 is independently associated with all-cause mortality after primary CABG surgery in whites and significantly improves the predictive value of the logistic EuroSCORE. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00281164.
Authors: E Braunwald; E M Antman; J W Beasley; R M Califf; M D Cheitlin; J S Hochman; R H Jones; D Kereiakes; J Kupersmith; T N Levin; C J Pepine; J W Schaeffer; E E Smith; D E Steward; P Theroux; J S Alpert; K A Eagle; D P Faxon; V Fuster; T J Gardner; G Gregoratos; R O Russell; S C Smith Journal: J Am Coll Cardiol Date: 2000-09 Impact factor: 24.094
Authors: Bernard L Croal; Graham S Hillis; Patrick H Gibson; Mohammed T Fazal; Hussein El-Shafei; George Gibson; Robert R Jeffrey; Keith G Buchan; Douglas West; Brian H Cuthbertson Journal: Circulation Date: 2006-09-25 Impact factor: 29.690
Authors: Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng Journal: Lancet Date: 2004 Sep 11-17 Impact factor: 79.321
Authors: Eric Pasmant; Ingrid Laurendeau; Delphine Héron; Michel Vidaud; Dominique Vidaud; Ivan Bièche Journal: Cancer Res Date: 2007-04-15 Impact factor: 12.701
Authors: Ulrich H Frey; Jochen D Muehlschlegel; Jürgen Peters; Simon Body; Christoph Ochterbeck; Amanda A Fox; Stanton K Shernan; Charles D Collard; Peter Lichtner Journal: Anesthesiology Date: 2014-05 Impact factor: 7.892
Authors: Lasse Folkersen; Jonas Persson; Johan Ekstrand; Hanna E Agardh; Göran K Hansson; Anders Gabrielsen; Ulf Hedin; Gabrielle Paulsson-Berne Journal: Mol Med Date: 2012-05-09 Impact factor: 6.354
Authors: Robert L Lobato; William D White; Joseph P Mathew; Mark F Newman; Peter K Smith; Charles B McCants; John H Alexander; Mihai V Podgoreanu Journal: Circulation Date: 2011-09-13 Impact factor: 29.690
Authors: Yan Gong; Amber L Beitelshees; Rhonda M Cooper-DeHoff; Maximilian T Lobmeyer; Taimour Y Langaee; Jun Wu; Sharon Cresci; Michael A Province; John A Spertus; Carl J Pepine; Julie A Johnson Journal: Circ Cardiovasc Genet Date: 2011-03-03
Authors: Erik P A van Iperen; Suthesh Sivapalaratnam; S Matthijs Boekholdt; G Kees Hovingh; Stephanie Maiwald; Michael W Tanck; Nicole Soranzo; Jonathan C Stephens; Jennifer G Sambrook; Marcel Levi; Willem H Ouwehand; John Jp Kastelein; Mieke D Trip; Aeilko H Zwinderman Journal: Eur J Hum Genet Date: 2013-11-13 Impact factor: 4.246
Authors: Gijs W D Landman; Jana V van Vliet-Ostaptchouk; Nanne Kleefstra; Kornelis J J van Hateren; Iefke Drion; Klaas H Groenier; Rijk O B Gans; Harold Snieder; Marten H Hofker; Henk J G Bilo Journal: Cardiovasc Diabetol Date: 2012-11-07 Impact factor: 9.951